KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amgen (AMGN) Receivables - Other (2018 - 2024)

Amgen has reported Receivables - Other over the past 8 years, most recently at $521.0 million for Q4 2024.

  • Quarterly results put Receivables - Other at $521.0 million for Q4 2024, up 3.78% from a year ago — trailing twelve months through Dec 2024 was $521.0 million (up 3.78% YoY), and the annual figure for FY2024 was $521.0 million, up 3.78%.
  • Receivables - Other for Q4 2024 was $521.0 million at Amgen, up from $502.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for AMGN hit a ceiling of $700.0 million in Q4 2022 and a floor of $21.0 million in Q4 2021.
  • Median Receivables - Other over the past 5 years was $502.0 million (2023), compared with a mean of $392.0 million.
  • Biggest five-year swings in Receivables - Other: plummeted 90.28% in 2021 and later surged 3233.33% in 2022.
  • Amgen's Receivables - Other stood at $216.0 million in 2020, then plummeted by 90.28% to $21.0 million in 2021, then surged by 3233.33% to $700.0 million in 2022, then fell by 28.29% to $502.0 million in 2023, then increased by 3.78% to $521.0 million in 2024.
  • The last three reported values for Receivables - Other were $521.0 million (Q4 2024), $502.0 million (Q4 2023), and $700.0 million (Q4 2022) per Business Quant data.